Oct 26, 2026 · 9 min
Meta seeks AI funding as Tesla rides SpaceX speculation
Meta’s $95 Billion Stock Offering; Moderna Down; Tesla Shares Up
The episode connects three market-moving stories with broader questions about AI investment, urban infrastructure, and the talent demands behind ambitious technology companies.
- 1Meta’s proposed $95 billion stock offering would fund AI investments, putting capital needs at the center of its strategy.
- 2Moderna continued to fall after disappointing pancreatic-cancer vaccine trial results weighed on investor confidence.
- 3Tesla gained after a Barclays upgrade linked optimism partly to potential SpaceX-related M&A and higher analyst targets.
Don't miss
Tesla’s rise is tied partly to speculation about potential SpaceX-related M&A and a more optimistic Barclays outlook.
The brief
Meta is fluctuating after announcing a proposed $95 billion stock offering to fund AI investments, making the cost of its technology ambitions a central market question.
Tatiana Daria joins Bloomberg’s stock-movers discussion as Moderna continues declining after disappointing pancreatic-cancer vaccine trial results, while Tesla rises after a Barclays upgrade.
Tesla’s gains reflect optimism tied partly to potential SpaceX-related M&A and increasingly positive analyst targets, linking two closely watched technology stories.
The episode then turns to smart cities, asking how AI and long-term planning can help rapidly growing urban areas; Dubai serves as a prominent example.
A final Bloomberg Tech Minute examines SpaceX’s demanding hiring culture, where demonstrated achievement, loyalty, and practical experience may outweigh advanced degrees.
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.